Clinical Trial Update: Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating the combination of sintilimab with AVD (doxorubicin, vinblastine, and dacarbazine) in pediatric patients with low- to moderat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• DTIC-Dome (dacarbazine)
• Tyvyt (Sintilimab)
• Velban (vinblastine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Classical Hodgkin Lymphoma | Phase 2 | Status: RECRUITING